Leo Bournaud-Froelicher
Paris, 75014, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Urinary rezafungin exposure: First human reports of quantification and early pharmacokinetic insights.
Journal: The Journal of infection
Published: March 13, 2026
Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 24, 2025
Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.
Journal: British journal of clinical pharmacology
Published: October 14, 2025
Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 02, 2025
Maternal-Fetal Letermovir Exposure In Vivo and Physiologically Based Pharmacokinetic Modeling: A Rationale for Congenital Cytomegalovirus Therapy.
Journal: The Journal of infectious diseases
Published: August 15, 2025
Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy.
Journal: The Journal of infectious diseases
Published: August 15, 2025
Pharmacokinetics of cefotaxime and its metabolite desacetyl-cefotaxime to optimize dosing in critically ill children and children with sickle cell disease.
Journal: The Journal of antimicrobial chemotherapy
Published: August 01, 2025
LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 18, 2025
Is cefazolin an option for treatment of staphylococcal endogenous endophthalmitis?
Journal: The Journal of antimicrobial chemotherapy
Published: May 26, 2025
Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis.
Journal: Clinical pharmacokinetics
Published: April 23, 2025
Paracetamol Concentrations and Time-Course of Ductus Arteriosus Diameter in Extremely Preterm Neonates: A Population Pharmacokinetic-Pharmacodynamic Analysis.
Journal: Clinical pharmacokinetics
Published: March 12, 2025
Ceftazidime-Avibactam Pharmacokinetic Comparative In Vivo/In Vitro Study in a Critically Ill Children Under High-Volume Continuous Venovenous Hemodiafiltration.
Journal: Pharmacology research & perspectives
Published: March 11, 2025
Last Updated: 09/26/2026